Chicago Tumor Institute - IL Cook, Chicago 60637

Chicago Tumor Institute entered the industry of Noncommercial Research Organizations in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541720, which describes it as a Noncommercial Research Organizations. For further clarification, the SIC classifies this business under the code 8733 and described it as a Noncommercial Research Organizations. The business provides service to the B2B market.

To acquire more information, please contact by calling (773) 702-1941 during business hours. You can also write to the business’ Single Location at 5801 South Ellis Avenue, Chicago, Illinois IL 60637. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Chicago Tumor Institute
Place of Business: 5801 South Ellis Avenue, Chicago, IL 60637
Contact Number: (773) 702-1941
Type of Service: Noncommercial Research Organizations
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2011
Income/Year: $0 to $49.999
Laborers: 1 to 4
Share This Company:

Chicago Tumor Institute is a company operating from Cook, Illinois providing professional Noncommercial Research Organizations and relevant B2B variables. It was founded in 2011 and registered with the SIC code 8733 as Noncommercial Research Organizations, and with the NAICS code 541720 as Noncommercial Research Organizations.

With a current employee count of 1 to 4, Chicago Tumor Institute has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative at (773) 702-1941 for related queries, or to locate its Single Location using the coordinates 41.790189,-87.601066.

The Single Location can also be found at the street address 5801 South Ellis Avenue in Chicago, Illinois 60637 and can be engaged online through the company website at , the company Twitter , and Facebook page .